Conferences - Results from #360

WCET 2024: Robotic Simple Prostatectomy Followed by Radiation Therapy Versus Robotic Radical Prostatectomy: Propensity Matched Analysis of a Treatment Pathway for Men with Prostate Cancer and Prostatomegaly August 13, 2024

WCET 2024: Panel: Artificial Intelligence (AI) in Endourology and Robotic Surgery August 13, 2024

WCET 2024: Debate: Is Open Surgery Training Necessary in the Era of Robotics? August 13, 2024

WCET 2024: State of the Art Lecture: The Role of Adjuvant and Salvage Radiation Therapy for Prostate Cancer August 13, 2024

WCET 2024: Impact of Tumor Volume and Surgical Margins on Mortality Post-Robotic Radical Prostatectomy August 13, 2024

WCET 2024: Development of Patient-Specific Nomogram for Clinical Decision-Making Between Single-Port versus Multi-Port Robotic Partial Nephrectomy: A Report from the Single Port Advanced Robotic Consortium August 13, 2024

WCET 2024: Holmium Laser Versus Transurethral Resection of the Bladder Tumor for Non-Muscle Invasive Bladder Cancer: a 2-Year Follow-up Clinical Trial August 12, 2024

WCET 2024: The Prostate Microbiome is Associated with Prostate Size in BPH Patients August 12, 2024

WCET 2024: Evaluation of Thermal Injury During Treatment of Kidney and Ureteral Stones with the Thulium Fiber Laser: Insights from an In-Vivo Porcine Model August 12, 2024

WCET 2024: Leveraging A Machine Learning Model To Predict Kidney Stone Composition: Implications For Treatment And Pathophysiology August 12, 2024

BCANTT 2024: Rationally Engineered IL2 for Enhanced Treatment of Local and Metastatic Bladder Cancer August 10, 2024

BCANTT 2024: Setting the Stage: BCG Unresponsive Disease August 10, 2024

BCANTT 2024: Identifying Genetic Determinants and Vulnerabilities of Histologic Variants of Bladder Cancer August 10, 2024

BCANTT 2024: Bladder Cancer Surveillance: Is Less More? August 10, 2024

BCANTT 2024: Dissecting the Impact of E-Cadherin Loss on the Immune Microenvironment August 10, 2024

BCANTT 2024: Exploring FGFR3 Inhibition as a Sensitizing Agent to Nectin-4 Antibody Drug Conjugate Therapy in Urothelial Carcinoma August 9, 2024

BCANTT 2024: Using Implementation Science to Improve Surveillance for Early-Stage Bladder Cancer August 9, 2024

BCANTT 2024: Bladder Cancer Care Implementation: NCCN Bladder Cancer Guidelines August 9, 2024

BCANTT 2024: A Rapid Intro to Implementation Science August 9, 2024

BCANTT 2024: Implementation of Smoking Cessation for Patients with Bladder Cancer August 9, 2024

Page 19 of 594